A5087281739- Global Cancer Incidence and Screening
- Economic and Financial Impacts of Cancer
- Advances in Oncology and Radiotherapy
- Health Systems, Economic Evaluations, Quality of Life
- Global Health and Surgery
- Childhood Cancer Survivors' Quality of Life
- Cervical Cancer and HPV Research
- COVID-19 and healthcare impacts
- Colorectal Cancer Screening and Detection
- Pharmaceutical Economics and Policy
- Global Public Health Policies and Epidemiology
- Child and Adolescent Health
- Global Health Workforce Issues
- Healthcare cost, quality, practices
- Global Health Care Issues
- Acute Lymphoblastic Leukemia research
- Ethics in Clinical Research
- Cancer Risks and Factors
- Palliative Care and End-of-Life Issues
- Cancer Genomics and Diagnostics
- Family Support in Illness
- Delphi Technique in Research
- Diversity and Career in Medicine
- Organ Donation and Transplantation
- BRCA gene mutations in cancer
World Health Organization
2017-2025
World Health Organization - Pakistan
2017-2023
Children's Hospital of Philadelphia
2023
Hospital Sírio-Libanês
2023
The University of Texas MD Anderson Cancer Center
2014-2019
UNSW Sydney
2018
Institute of Social and Preventive Medicine
2018
Fred Hutch Cancer Center
2017
Leidos (United States)
2017
World Health Organization Regional Office for the Americas
2017
WHO is developing a global strategy towards eliminating cervical cancer as public health problem, which proposes an elimination threshold of four cases per 100 000 women and includes 2030 triple-intervention coverage targets for scale-up human papillomavirus (HPV) vaccination to 90%, twice-lifetime screening 70%, treatment pre-invasive lesions invasive 90%. We assessed the impact achieving 90-70-90 on mortality deaths averted over next century. also potential initiative support target 3.4 UN...
The cancer burden is rising globally, exerting significant strain on populations and health systems at all income levels. In May 2017, world governments made a commitment to further invest in control as public priority, passing the World Health Assembly Resolution 70.12 prevention within an integrated approach. this manuscript, 2016 European Society for Medical Oncology Leadership Generation Programme participants propose strategic framework that line with 2017 WHO Cancer consistent...
The WHO Essential Medicines List (EML) identifies priority medicines that are most important to public health. Over time, the EML has included an increasing number of cancer medicines. We aimed investigate whether in aligned with frontline oncologists worldwide, and extent which these accessible routine clinical practice.This international, cross-sectional survey was developed by investigators from a range practice settings across low-income high-income countries, including members Cancer...
Despite women being disproportionally affected by cancer deaths at young ages, there are no global estimates of the resulting maternal orphans, who experience health and education disadvantages throughout their lives. We estimated number children became orphans in 2020 due to mother dying from that year, for 185 countries worldwide cause cancer-related death. Female deaths-by country, type age (derived GLOBOCAN estimates)-were multiplied each woman's under 18 years time her death (fertility...
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate cervical cancer as public health problem. To support strategy, WHO published updated screening guidelines in 2021. inform this update, we used an established modeling platform, Policy1-Cervix , evaluate impact of seven primary scenarios across 78 low- and lower-middle-income countries (LMICs) for general population women. Assuming 70% coverage, found that human papillomavirus (HPV) approaches were most...
To curb the rising global burden of non-communicable diseases (NCDs), UN Sustainable Development Goals (SDGs) include a target to reduce premature mortality from NCDs by third 2030. A quantitative assessment effect on longevity meeting this is one many important measures needed advocate and inform national disease control policies. We did analysis estimate improvements in average expected years lived between 30 70 age that would result SDG target.We estimated age-specific 183 countries 2015,...
<h3>Importance</h3> High costs and risks of research development (R&D) have been used to justify the high prices cancer drugs. However, what return on R&D investment is, by extension a justifiable price might be, is unclear. <h3>Objective</h3> To compare incomes from sales drugs with estimated costs. <h3>Design, Setting, Participants</h3> This observational study global pharmaceutical industry data quantify cumulative generated for companies that held patents or marketing rights...
Cancer control planning has become a core aspect of global health, as rising rates noncommunicable diseases in low-resource settings have fittingly propelled it into the spotlight. Comprehensive strategies for cancer are needed to effectively manage disease burden. As most common among women and likely reason woman will die from globally, breast management is necessary any comprehensive plan. Major improvements outcomes high-income countries not yet been mirrored settings, making targeted...